Bio Essence Corp. Relocates Principal Executive Offices

TL;DR

Bio Essence Corp. moved its HQ to Irvine, CA.

AI Summary

Bio Essence Corp. announced on June 18, 2024, a change in its principal executive offices to 12 Chrysler, Unit B, Irvine, CA 92618. The company also filed a current report detailing this relocation and other standard corporate updates.

Why It Matters

A change in principal executive offices can indicate operational shifts or growth for a company, potentially impacting its local business environment and investor perception.

Risk Assessment

Risk Level: low — This filing is a routine corporate update regarding office relocation and does not contain significant financial or strategic information that would inherently increase risk.

Key Players & Entities

• Bio Essence Corp. (company) — Registrant
• 12 Chrysler, Unit B, Irvine, CA 92618 (location) — New Principal Executive Offices
• June 18, 2024 (date) — Date of Report

FAQ

Filing Documents

• ea0208076-8k_bio.htm (8-K) — 26KB
• ea020807601ex99-1_bio.htm (EX-99.1) — 9KB
• ea020807601ex99-2_bio.htm (EX-99.2) — 47KB
• 0001213900-24-054715.txt ( ) — 262KB
• bioe-20240618.xsd (EX-101.SCH) — 3KB
• bioe-20240618_lab.xml (EX-101.LAB) — 33KB
• bioe-20240618_pre.xml (EX-101.PRE) — 22KB
• ea0208076-8k_bio_htm.xml (XML) — 3KB

02 Departure of Directors or Certain Officers; Election of

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 12, 2024, Yangyang Huang and Simon Shavanson (collectively the "Resigning Directors") resigned from the Board of Directors of Bio Essence Corp. (the "Company"). The Company received confirmation of their resignation on or about June 14, 2024. The Resigning Directors' decision was not based on any material dispute or as defined in 17 CFR 240.3b-7, and as such this disclosure is made pursuant to Item 5.02(b). On June 18, 2024, the Company's remaining directors unanimously appointed William Sluss to the Board of Directors pursuant to Article II, Section 6 of the Company's Bylaws. Mr. Sluss serves as the Company's Chief Financial Officer. There were no arrangements or material understandings between Mr. Sluss and the remaining Board of Directors, as the Board of Directors believe that Mr. Sluss's experience as the Chief Financial Officer of the Company makes him well equipped to assist in board-level decisions. There is no material arrangement, plan, or contract between Mr. Sluss and the Company in relation to his service on the Board of Directors, and no transactions that require disclosure pursuant to

(a) of Regulation S-K

Item 404(a) of Regulation S-K. SECTION 8- OTHER EVENTS

01 Other Events

Item 8.01 Other Events The Company has adopted an Insider Trading Policy ("Policy") effective the date of this Current Report. The Policy is attached hereto as an exhibit.

01 Financial

Item 9.01 Financial Exhibit No. Description 99.1 Consent Resolution of the Board of Directors 99.2 Insider Trading Policy 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO ESSENCE CORP. /s/ Yin Yan By: Yin Yan Its: Chief Executive Officer Dated: June 21, 2024 2

View Full Filing

View this 8-K filing on SEC EDGAR